The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The metric has seen a significant gain of 414.17% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 36.76%. Over the past 30 days, the price of JANX has fallen by 13.01%. And in the last five days, it has surged by 0.07%.
Janux Therapeutics Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $71.71 on 12/05/24 and a low of $7.79 for the same time frame on 02/05/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of JANX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Janux Therapeutics Inc’s current trading price is -23.07% away from its 52-week high, while its distance from the 52-week low is 608.22%. The stock’s price range during this period has varied between$7.79 and $71.71. The Janux Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.67 million for the day, a figure considerably lower than their average daily volume of 0.96 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Janux Therapeutics Inc (JANX) has experienced a quarterly rise of 18.34% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.19B and boasts a workforce of 64 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 49.53, with a change in price of +17.94. Similarly, Janux Therapeutics Inc recorded 813,733 in trading volume during the last 100 days, posting a change of +48.19%.
JANX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for JANX stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.03.
JANX Stock Stochastic Average
Janux Therapeutics Inc’s raw stochastic average for the past 50 days is presently 47.81%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 47.81%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 49.85% and 51.20%, respectively.
